Ratings Green Thumb Industries Inc.

Equities

GTII

CA39342L1085

Market Closed - Canadian Securities Exchange Other stock markets 03:59:59 2024-04-18 pm EDT			5-day change	1st Jan Change
17.74 ^CAD	0.00%		-7.99%	+19.30%

Mar. 27	Green Thumb Industries Insider Sold Shares Worth $258,256, According to a Recent SEC Filing	MT
Mar. 26	Green Thumb Industries Insider Sold Shares Worth $297,426, According to a Recent SEC Filing	MT

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation
According to Refinitiv, the company's ESG score for its industry is poor.

Strengths

The company's profit outlook over the next few years is a strong asset.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

With an expected P/E ratio at 65.3 and 55.75 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The valuation of the company is particularly high given the cash flows generated by its activity.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last few months, analysts have been revising downwards their earnings forecast.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Drug Retailers

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
GREEN THUMB INDUSTRIES INC.	+19.30%	3.06B		D+
GLASS HOUSE BRANDS INC.	+86.05%	628M		-
TERRASCEND CORP.	+7.73%	502M		-
HIGH TIDE INC.	+43.19%	176M		-
CANTOURAGE GROUP SE	+5.85%	101M	-	-
MARIMED INC.	+0.62%	105M		-
NOVA CANNABIS INC.	+82.02%	67.55M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes